EGFR and non-small cell lung carcinoma: We hypothesized that miRNA-125a-5p would enhance the sensitivity of the NSCLC cells to EGFR-TKIs by EGFR silencing, and evaluated the combination effect of miRNA-125a-5p and erlotinib on A549 cells.